FATE - Fate Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.16B
Enterprise Value 31.02B
Trailing P/E N/A
Forward P/E 1-13.93
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)183.15
Price/Book (mrq)7.96
Enterprise Value/Revenue 3161.02
Enterprise Value/EBITDA 6-14.17

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,157.96%

Management Effectiveness

Return on Assets (ttm)-29.23%
Return on Equity (ttm)-68.51%

Income Statement

Revenue (ttm)6.35M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)156.50%
Gross Profit (ttm)-51.28M
EBITDA -72.13M
Net Income Avi to Common (ttm)-72.22M
Diluted EPS (ttm)-1.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)183.03M
Total Cash Per Share (mrq)2.81
Total Debt (mrq)42.62M
Total Debt/Equity (mrq)29.22
Current Ratio (mrq)6.40
Book Value Per Share (mrq)2.24

Cash Flow Statement

Operating Cash Flow (ttm)-43.59M
Levered Free Cash Flow (ttm)-29.83M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.50
52-Week Change 353.81%
S&P500 52-Week Change 34.25%
52 Week High 320.65
52 Week Low 38.64
50-Day Moving Average 318.02
200-Day Moving Average 316.31

Share Statistics

Avg Vol (3 month) 3712.62k
Avg Vol (10 day) 3772.63k
Shares Outstanding 565.19M
Float 52.74M
% Held by Insiders 12.29%
% Held by Institutions 196.71%
Shares Short (May 31, 2019) 48.26M
Short Ratio (May 31, 2019) 49.59
Short % of Float (May 31, 2019) 424.09%
Short % of Shares Outstanding (May 31, 2019) 412.67%
Shares Short (prior month Apr 30, 2019) 49.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A